“Not knowing is not the right answer ... You have loved ones counting on you.” According to the CDC, cancer is one of the leading causes of death for firefighters in the US. Firefighter leaders understand that the earlier you detect health issues like cancer, the sooner you can act. Watch how they’re changing the narrative on occupational cancer risk by using tools like the Galleri multi-cancer early detection (MCED) test as part of annual screenings for their members. Go further with Galleri: https://bit.ly/4fKTDLc Galleri should be used in addition to healthcare provider recommended screening tests. The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. Rx only. Important Safety Information: https://bit.ly/33m8pFa #CancerScreening #FirefighterCancer #OccupationalCancer
关于我们
This Galleri? test is a multi-cancer early detection test that looks for a signal shared by 50+ types of cancer with a single blood test.* The Galleri? LinkedIn showcase page is intended for US Residents only. Visit Galleri.com to see Important Safety Information and learn more. Rx only. Galleri should be used in addition to recommended screenings. The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative signal results do occur. ? 2023 GRAIL, LLC. ALL RIGHTS RESERVED. GALLERI IS A REGISTERED TRADEMARK OF GRAIL, LLC. * Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021;32(9):1167-77. DOI: https://doi.org/10.1016/j.annonc.2021.05.806.
- 网站
-
https://www.galleri.com
Galleri Test的外部链接
- 所属行业
- 生物技术研究
- 规模
- 201-500 人
- 总部
- Menlo Park,California
- 创立
- 2020
- 领域
- Cancer Detection、Cancer Biology、Cancer Screening、Cancer Test、Multi-Cancer Test和Early Cancer Detection
动态
-
We understand the challenges providers face when integrating new technologies into their practice. The Galleri test only requires a simple blood draw, fitting seamlessly into existing patient touchpoints like annual health checks or routine blood work. "As an OB-GYN, I see cancers specific to my practice. When a Cancer Signal Detected result indicates a cancer [origin] I'm unfamiliar with, Galleri's team connects me with specialists who provide the support I need. The effort is worth it for the [potential for] life-changing outcomes." - Dr. Candace Westgate, DO Find out more about the Galleri test: https://bit.ly/4dQhasK See Important Safety Information: https://bit.ly/33m8pFa Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. Galleri should be used in addition to healthcare provider recommended screening tests. The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Based on a clinical study of people ages 50 to 79, around 1% are expected to receive a Cancer Signal Detected result. After diagnostic evaluation, around 40% of these people are expected to have a confirmed cancer diagnosis. #Cancer #MultiCancerEarlyDetection #CancerScreening
-
Mike was living life without any symptoms. After deciding to take the Galleri multi-cancer early detection (MCED) test using FSA/HSA funds at the encouragement of his girlfriend, he received an unexpected Cancer Signal Detected result with a predicted origin of head and neck. This helped his care team at Mercy move quickly, guiding the next steps to confirm a diagnosis of stage 2 tonsil cancer. Mike’s story shares the importance of being proactive about your health. Watch below. ?? Rx only. Important Safety Information: https://bit.ly/33m8pFa #MCED #CancerScreening #PatientStory You may be able to use your health savings account (HSA) or flexible spending account (FSA) to pay for the test. Check with your insurer or account administrator to determine eligibility. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. Galleri should be used in addition to healthcare provider recommended screening tests. The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Based on a clinical study of people ages 50 to 79, around 1% are expected to receive a "Cancer Signal Detected" result. After diagnostic evaluation, around 40% of these people are expected to have a confirmed cancer diagnosis. The overall sensitivity in study participants with head and neck cancer was 85.7% (63.2% for stage I, 82.4% stage II, 84.2% stage III, 96.0% stage IV).
-
?? Maintain a clear snapshot of your health with multi-cancer early detection (MCED). Dr. Candace Westgate knows that adding MCED testing alongside recommended cancer screenings can help increase the chance of finding a cancer signal early, before symptoms appear and when treatment may be more effective.1 That’s why she recommends the Galleri test as part of her patients' annual exams. Make MCED a part of your cancer screening plan: https://bit.ly/4dJcXXP Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. Galleri should be used in addition to healthcare provider recommended screening tests. The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. #CancerScreening #MCED #WellnessExam Reference: 1. Schrag D, Beer TM, McDonnell CH, et al. Blood-based tests for multi-cancer early detection (PATHFINDER): a prospective cohort study. Lancet. 2023;402:1251-1260. doi: 10.1016/S0140-6736(23)01700-2
-
Thank you to everyone who attended our first session on advances in cancer screening and navigation at the 70th Annual Employee Benefits Conference! If you missed out today, join us tomorrow for your last chance to explore cutting edge technology, clinical data, and case study examples on the benefits of adding multi-cancer early detection (MCED) testing to your employee health plan. #EmployeeBenefits #EmployeeHealth #MCED #MultiCancerEarlyDetection Rx only. Important Safety Information: https://bit.ly/33m8pFa
-
Take advantage of your health benefits before the year ends and invest in your health with the Galleri multi-cancer early detection test. You may be able to use your health savings account (HSA) or flexible spending account (FSA) to pay for the test. Check with your insurer or account administrator to determine eligibility. Explore our payment options: https://bit.ly/3Yp1Ihx #HSA #FSA #Healthcare #CancerScreening Rx only. Important Safety Information: https://bit.ly/33m8pFa The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative signal results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. The Galleri test should be used in addition to healthcare provider recommended screening tests.
-
We’ll see you in San Diego at the International Foundation of Employee Benefit Plans (IFEBP) 2024 Annual Employee Benefits Conference! Join Megan Hall, Adam Bradley, and Greg Trento to discover cancer’s unique impact on unions and their members and how you can do more for your employee’s health by adding multi-cancer early detection (MCED) testing to your benefits mix. Register: https://bit.ly/3XNX901 #EmployeeBenefits #EmployeeHealth #MCED #MultiCancerEarlyDetection Rx only. Important Safety Information: https://bit.ly/33m8pFa
-
One of the scariest parts of cancer is that many types remain asymptomatic until later stages — when treatment options may be less effective.1?2 Adding the Galleri test to your regular wellness visits can improve the chance of finding a cancer early when more treatment options may be available.3 Learn more about screening with Galleri: https://bit.ly/3Alfnyi #Halloween #CancerScreening #DetectCancerEarly #Galleri? Rx only. Important Safety Information: https://bit.ly/33m8pFa? The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. The Galleri test should be used in addition to healthcare provider recommended screening tests. The Galleri test looks for a signal associated with cancer and does not predict future genetic risk for cancer.? References: 1. American Cancer Society. The cancer atlas. [Internet] Early detection. https://bit.ly/4hpZh79 2. Etzioni R, Urban N, Ramsey S, et al. The case for early detection. Nat Rev Cancer. 2003 Apr;3(4):243-52. doi: 10.1038/nrc1041 3. Schrag D, Beer TM, McDonnell CH, et al. Blood-based tests for multi-cancer early detection (PATHFINDER): a prospective cohort study. Lancet. 2023;402:1251-1260. doi: 10.1016/S0140-6736(23)01700-2
-
#BreastCancerAwarenessMonth is a great time to remember to schedule your annual breast cancer screening and talk to your doctor about your cancer screening plan. The Galleri test is a multi-cancer early detection test that identifies a “fingerprint” of many of the deadliest cancers before they become symptomatic.1?2 It is a screening test and does not diagnose cancer; further testing is required to confirm cancer if a signal is detected. Download our patient+provider discussion guide at https://bit.ly/48Hu3ol to take to your next appointment and start the conversation about the Galleri test with your primary care provider. #CancerScreening #MultiCancerEarlyDetection #Galleri Rx only. Important Safety Information: https://bit.ly/33m8pFa The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. The Galleri test should be used in addition to healthcare provider recommended screening tests. 1 in 100 can expect to receive a CSD result, and approximately 40% of these individuals will receive a confirmed cancer diagnosis. References: 1. Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021 Sep;32(9):1167-77. doi: 10.1016/j.annonc.2021.05.806 2. Schrag D, Beer TM, McDonnell CH, et al. Blood-based tests for multi-cancer early detection (PATHFINDER): a prospective cohort study. Lancet. 2023;402:1251-1260. doi: 10.1016/S0140-6736(23)01700-2
-
Dr. Candace Westgate's journey into the cancer space began after diagnosing a patient with a BRCA1 mutation, igniting her passion for cancer risk assessment, prevention, and early detection. With her background in cell-free DNA analysis through non-invasive prenatal testing (NIPT), she recognized the revolutionary potential of multi-cancer early detection (MCED) screening with the Galleri test. See how MCED is helping physicians like Dr. Westgate go further with cancer screening: https://bit.ly/3Y64YOX See Important Safety Information: https://bit.ly/33m8pFa Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. Galleri should be used in addition to healthcare provider recommended screening tests. The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. #CancerScreening #Galleri #MCED